Interaction between α-Synuclein and Bioactive Lipids: Neurodegeneration, Disease Biomarkers and Emerging Therapies
The present review provides a comprehensive examination of the intricate dynamics between α-synuclein, a protein crucially involved in the pathogenesis of several neurodegenerative diseases, including Parkinson’s disease and multiple system atrophy, and endogenously-produced bioactive lipids, which...
| Published in: | Metabolites |
|---|---|
| Main Authors: | Chiara Sanluca, Paolo Spagnolo, Romina Mancinelli, Maria Ilenia De Bartolo, Marina Fava, Mauro Maccarrone, Simone Carotti, Eugenio Gaudio, Alessandro Leuti, Giorgio Vivacqua |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-06-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-1989/14/7/352 |
Similar Items
Overlaps and divergences between tauopathies and synucleinopathies: a duet of neurodegeneration
by: Wen Li, et al.
Published: (2024-03-01)
by: Wen Li, et al.
Published: (2024-03-01)
Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
by: Julia E. Gerson, et al.
Published: (2018-03-01)
by: Julia E. Gerson, et al.
Published: (2018-03-01)
Editorial: The Protein Alpha-Synuclein: Its Normal Role (in Neurons) and Its Role in Disease
by: Ruth G. Perez
Published: (2020-02-01)
by: Ruth G. Perez
Published: (2020-02-01)
Inflammation kinase PKR phosphorylates α-synuclein and causes α-synuclein-dependent cell death
by: Lasse Reimer, et al.
Published: (2018-07-01)
by: Lasse Reimer, et al.
Published: (2018-07-01)
A Single Chain Fragment Variant Binding Misfolded Alpha-Synuclein Exhibits Neuroprotective and Antigen-Specific Anti-Inflammatory Properties
by: Michael Fassler, et al.
Published: (2022-11-01)
by: Michael Fassler, et al.
Published: (2022-11-01)
Inhibiting the mitochondrial pyruvate carrier does not ameliorate synucleinopathy in the absence of inflammation or metabolic deficits
by: Wouter Peelaerts, et al.
Published: (2020-11-01)
by: Wouter Peelaerts, et al.
Published: (2020-11-01)
Structural and Functional Insights into α-Synuclein Fibril Polymorphism
by: Surabhi Mehra, et al.
Published: (2021-09-01)
by: Surabhi Mehra, et al.
Published: (2021-09-01)
Interactions of alpha-synuclein with membranes in Parkinson's disease: Mechanisms and therapeutic strategies
by: Baoyi Li, et al.
Published: (2024-10-01)
by: Baoyi Li, et al.
Published: (2024-10-01)
The effect of AKT inhibition in α-synuclein-dependent neurodegeneration
by: Bedri Ranxhi, et al.
Published: (2025-02-01)
by: Bedri Ranxhi, et al.
Published: (2025-02-01)
A systematic review of salivary biomarkers in Parkinson’s disease
by: Maria Ilenia De Bartolo, et al.
Published: (2024-01-01)
by: Maria Ilenia De Bartolo, et al.
Published: (2024-01-01)
From the baker to the bedside: yeast models of Parkinson's disease
by: Regina Menezes, et al.
Published: (2015-07-01)
by: Regina Menezes, et al.
Published: (2015-07-01)
Monitoring α-synuclein aggregation
by: Juan Estaun-Panzano, et al.
Published: (2023-01-01)
by: Juan Estaun-Panzano, et al.
Published: (2023-01-01)
The role of autophagy in synucleinopathy: clearance versus spread of α-synuclein
by: Emily Birnbaum, et al.
Published: (2025-12-01)
by: Emily Birnbaum, et al.
Published: (2025-12-01)
Production of Recombinant Alpha-Synuclein: Still No Standardized Protocol in Sight
by: Mohammed Al-Azzani, et al.
Published: (2022-02-01)
by: Mohammed Al-Azzani, et al.
Published: (2022-02-01)
Alpha-Synuclein Accumulation and Its Phosphorylation in the Enteric Nervous System of Patients Without Neurodegeneration: An Explorative Study
by: Lu-Lu Bu, et al.
Published: (2020-11-01)
by: Lu-Lu Bu, et al.
Published: (2020-11-01)
Alpha-Synuclein PET Tracer Development—An Overview about Current Efforts
by: Špela Korat, et al.
Published: (2021-08-01)
by: Špela Korat, et al.
Published: (2021-08-01)
Mechanism of Anti-α-Synuclein Immunotherapy
by: Jun Sung Lee, et al.
Published: (2016-01-01)
by: Jun Sung Lee, et al.
Published: (2016-01-01)
Alpha-synuclein inclusion responsive microglia are resistant to CSF1R inhibition
by: Anna C. Stoll, et al.
Published: (2024-04-01)
by: Anna C. Stoll, et al.
Published: (2024-04-01)
Sensitivity of Detecting Alpha-Synuclein Accumulation in the Gastrointestinal Tract and Tissue Volume Examined
by: Chaewon Shin, et al.
Published: (2022-09-01)
by: Chaewon Shin, et al.
Published: (2022-09-01)
Oxidative Stress and Neurodegeneration: Insights and Therapeutic Strategies for Parkinson’s Disease
by: Erjola Bej, et al.
Published: (2024-04-01)
by: Erjola Bej, et al.
Published: (2024-04-01)
Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles
by: Selene Seoyun Lee, et al.
Published: (2024-11-01)
by: Selene Seoyun Lee, et al.
Published: (2024-11-01)
α-synuclein and tau: interactions, cross-seeding, and the redefinition of synucleinopathies as complex proteinopathies
by: Francisco J. Padilla-Godínez, et al.
Published: (2025-03-01)
by: Francisco J. Padilla-Godínez, et al.
Published: (2025-03-01)
Phytochemicals as Regulators of Genes Involved in Synucleinopathies
by: Andrei Surguchov, et al.
Published: (2021-04-01)
by: Andrei Surguchov, et al.
Published: (2021-04-01)
A New Rise of Non-Human Primate Models of Synucleinopathies
by: Margaux Teil, et al.
Published: (2021-03-01)
by: Margaux Teil, et al.
Published: (2021-03-01)
Peptide-based approaches to directly target alpha-synuclein in Parkinson’s disease
by: Scott G. Allen, et al.
Published: (2023-11-01)
by: Scott G. Allen, et al.
Published: (2023-11-01)
Alpha-Synuclein Physiology and Pathology: A Perspective on Cellular Structures and Organelles
by: Luis D. Bernal-Conde, et al.
Published: (2020-01-01)
by: Luis D. Bernal-Conde, et al.
Published: (2020-01-01)
Seeding and transgenic overexpression of alpha‐synuclein triggers dendritic spine pathology in the neocortex
by: Sonja Blumenstock, et al.
Published: (2017-03-01)
by: Sonja Blumenstock, et al.
Published: (2017-03-01)
Alpha-Synuclein Dysregulation in Systemic Pathophysiology of Synucleinopathies
by: Hallie H. Dolin, et al.
Published: (2025-07-01)
by: Hallie H. Dolin, et al.
Published: (2025-07-01)
Icariin Inhibits Overexpression and Aggregation of α-Synuclein in A53T α-Synuclein Transgenic Mice by Regulating Parkin and PLK2
by: Denglei Ma, et al.
Published: (2023-11-01)
by: Denglei Ma, et al.
Published: (2023-11-01)
Fasudil inhibits α-synuclein aggregation through ROCK-inhibition-mediated mechanisms
by: Lucia Lage, et al.
Published: (2025-03-01)
by: Lucia Lage, et al.
Published: (2025-03-01)
Navigating the Neurobiology of Parkinson’s: The Impact and Potential of α-Synuclein
by: Erlandas Paulėkas, et al.
Published: (2024-09-01)
by: Erlandas Paulėkas, et al.
Published: (2024-09-01)
Misfolded α-synuclein causes hyperactive respiration without functional deficit in live neuroblastoma cells
by: Cathryn L. Ugalde, et al.
Published: (2020-01-01)
by: Cathryn L. Ugalde, et al.
Published: (2020-01-01)
Neurodegeneration: 2024 update
by: John F. Crary
Published: (2024-12-01)
by: John F. Crary
Published: (2024-12-01)
Neurodegeneration: 2023 update
by: John Fonda Crary
Published: (2023-09-01)
by: John Fonda Crary
Published: (2023-09-01)
Motor neuron loss and neuroinflammation in a model of α-synuclein-induced neurodegeneration
by: Zachary A. Sorrentino, et al.
Published: (2018-12-01)
by: Zachary A. Sorrentino, et al.
Published: (2018-12-01)
α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies
by: Matthias Schmitz, et al.
Published: (2023-03-01)
by: Matthias Schmitz, et al.
Published: (2023-03-01)
Rational Generation of Monoclonal Antibodies Selective for Pathogenic Forms of Alpha-Synuclein
by: Ebrima Gibbs, et al.
Published: (2022-09-01)
by: Ebrima Gibbs, et al.
Published: (2022-09-01)
A novel function for α-synuclein as a regulator of NCK2 in olfactory bulb: implications for its role in olfaction
by: Jing Ren, et al.
Published: (2024-11-01)
by: Jing Ren, et al.
Published: (2024-11-01)
Preclinical Detection of Alpha-Synuclein Seeding Activity in the Colon of a Transgenic Mouse Model of Synucleinopathy by RT-QuIC
by: Jung-Youn Han, et al.
Published: (2021-04-01)
by: Jung-Youn Han, et al.
Published: (2021-04-01)
α-Synuclein Conformational Plasticity: Physiologic States, Pathologic Strains, and Biotechnological Applications
by: Amanda Li, et al.
Published: (2022-07-01)
by: Amanda Li, et al.
Published: (2022-07-01)
Similar Items
-
Overlaps and divergences between tauopathies and synucleinopathies: a duet of neurodegeneration
by: Wen Li, et al.
Published: (2024-03-01) -
Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
by: Julia E. Gerson, et al.
Published: (2018-03-01) -
Editorial: The Protein Alpha-Synuclein: Its Normal Role (in Neurons) and Its Role in Disease
by: Ruth G. Perez
Published: (2020-02-01) -
Inflammation kinase PKR phosphorylates α-synuclein and causes α-synuclein-dependent cell death
by: Lasse Reimer, et al.
Published: (2018-07-01) -
A Single Chain Fragment Variant Binding Misfolded Alpha-Synuclein Exhibits Neuroprotective and Antigen-Specific Anti-Inflammatory Properties
by: Michael Fassler, et al.
Published: (2022-11-01)
